{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:23:30Z","timestamp":1791296610056,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003094","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:05:42Z","timestamp":1461330342000},"page":"e3094","source":"Crossref","is-referenced-by-count":51,"title":["Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients"],"prefix":"10.1097","volume":"95","author":[{"given":"Hyeyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Sung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-54-20210226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"R2-54-20210226","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-6143.2007.02104.x","article-title":"Transplant glomerulopathy","volume":"8","author":"Cosio","year":"2008","journal-title":"Am J Transplant"},{"key":"R3-54-20210226","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R4-54-20210226","first-page":"290","article-title":"Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.","volume":"265-","author":"Ozawa","year":"2006","journal-title":"Clin Transpl"},{"key":"R5-54-20210226","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R6-54-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humimm.2010.10.018","article-title":"Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation","volume":"72","author":"Kobayashi","year":"2011","journal-title":"Hum Immunol"},{"key":"R7-54-20210226","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"R8-54-20210226","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","article-title":"Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition","volume":"91","author":"Walsh","year":"2011","journal-title":"Transplantation"},{"key":"R9-54-20210226","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2012.190","article-title":"Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation","volume":"82","author":"DeVos","year":"2012","journal-title":"Kidney Int"},{"key":"R10-54-20210226","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"R11-54-20210226","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"R12-54-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R13-54-20210226","doi-asserted-by":"crossref","first-page":"e42011","DOI":"10.1371\/journal.pone.0042011","article-title":"Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS One"},{"key":"R14-54-20210226","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.trsl.2012.02.009","article-title":"Pretransplant IFN-gamma ELISPOT assay as a potential screening test to select immunosuppression protocols for patients receiving basiliximab induction therapy","volume":"160","author":"Kim","year":"2012","journal-title":"Transl Res"},{"key":"R15-54-20210226","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R16-54-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trre.2015.04.003","article-title":"Anti-human leukocyte antigen DQ antibodies in renal transplantation: are we underestimating the most frequent donor specific alloantibodies?","volume":"29","author":"Carta","year":"2015","journal-title":"Transplant Rev (Orlando"},{"key":"R17-54-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00372246","article-title":"Genetic and functional relationship of the HLA-DR and HLA-DQ antigens","volume":"21","author":"Navarrete","year":"1985","journal-title":"Immunogenetics"},{"key":"R18-54-20210226","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1523-1755.2001.059002488.x","article-title":"Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium","volume":"59","author":"Muczynski","year":"2001","journal-title":"Kidney Int"},{"key":"R19-54-20210226","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexmp.2012.05.005","article-title":"Decreased humoral antibody episodes of acute renal allograft rejection in recipients expressing the HLA-DQbeta1*0202 allele","volume":"93","author":"Mannam","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"R20-54-20210226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"R21-54-20210226","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"R22-54-20210226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.ki.5001552","article-title":"Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation","volume":"70","author":"Sun","year":"2006","journal-title":"Kidney Int"},{"key":"R23-54-20210226","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients","volume":"96","author":"Dorje","year":"2013","journal-title":"Transplantation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:19:59Z","timestamp":1620958799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003094","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}